is semaglutide still available from compounding pharmacies Troubling Findings in Study of GLP-1 Compounders Drugmakers battle pharmacies over compounded

doi: 10.1055/s-0032-1328878

A lot of plans dont cover weight management drugs or require prior authorization, so access is patchy

Red flags that suggest problematic marketing include: claims of pharmaceutical equivalence ("works just like Ozempic"), rapid weight loss promises (dramatic outcomes in short timeframes), proprietary blends without strain disclosure, astronomical CFU counts emphasized over strain quality, and unrealistic guarantee windows preventing adequate assessment

The productive combination strategy in research is pairing a GHRH analog (CJC-1295, sermorelin) with a single GHRP, because those two classes act on distinct receptor systems